Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. (Q44656909)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

main subject

phase II clinical trial

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Frederick R. Appelbaum

3

object named as

F R Appelbaum

1 reference

22 October 2019

J F Eary

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

P J Martin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

W B Nelp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

S Glenn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

D R Fisher

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

B Porter

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

D C Matthews

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Gooley

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

language of work or name

English

0 references

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

8971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

336-340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Preliminary validation of the opposing view method for quantitative gamma camera imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

The multichain interleukin-2 receptor: a target for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Durable remissions in stage III follicular lymphoma: interpret with caution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992225-3

7 January 2021

10.1016/S0140-6736(95)92225-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7623531%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference